ArticleFrontiers in neuroscience2025
A pilot study assessing the clinical utility of deep learning-reconstructed 3D-echo-planar-imaging-based quantitative susceptibility mapping in multiple sclerosis.
Article in Frontiers in neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Fast Submillimeter Whole-Brain TMagnetic resonance in medicine · 2026Article
- Complex Deep Neural Networks for Denoising Ultra-Fast Submillimeter T2*-weighted Imaging and Quantitative Susceptibility Mapping.European journal of radiology artificial intelligence · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Quantitative susceptibility mapping (QSM) has emerged as a promising paraclinical tool in multiple sclerosis (MS). This retrospective pilot study aims to evaluate whether a recently proposed deep learning-assisted, k-space-operating reconstruction, denoising and super-resolution technique (DLR) applied on 3D-echo-planar-imaging (3DEPI) protocols, has the potential to improve the quality and clinical utility of QSM in MS, at 3T. Secondarily, we assess whether applying DLR vs. a conventional reconstruction (CR) can improve the quality of QSM based on noise-susceptible, fast 3DEPI protocols. Methods: 3T MRI 3DEPI-data were acquired on seven MS patients and offline-reconstructed using CR and DLR. Results: Deep learning reconstruction-3DEPI-based QSM was rated significantly higher for the confidence in identification of the MS-specific biomarkers (hyper/isointense lesions: Conclusion: Our results constitute a first demonstration of the enhanced quality and clinical utility of the DLR-3DEPI-based QSM in MS.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.